טוען...
NAD(+) metabolism as a target for metabolic health: have we found the silver bullet?
NAD(+) has gone in and out of fashion within the scientific community a number of times since its discovery in the early 1900s. Over the last decade, NAD(+) has emerged as a potential target for combatting metabolic disturbances and the mitochondrial dysfunction that is mediated through sirtuin (SIR...
שמור ב:
| הוצא לאור ב: | Diabetologia |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509089/ https://ncbi.nlm.nih.gov/pubmed/30772929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-019-4831-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|